ArticleCancers2023

Longitudinal Assessment of Circulating Tumor Cells and Outcome in Small Cell Lung Cancer: A Sub-Study of RASTEN-A Randomized Trial with Low Molecular Weight Heparin.

Pär-Ola Bendahl et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.